Product Information
MELOXICAM 15 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.0184 per EA under NDC 60687019901. Its NADAC has been published 534 times since Jul 13, 2016.
FDA first approved this application on Jul 19, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
American Health PackagingNDC
60687019901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MELOXICAMApproval Type
Generic (ANDA)
FDA Application
ANDA077921FDA Approved
7/19/2006
TE Code
AB
On Market Since
6/1/2016
Pharmacological Classes
Price Statistics
The NADAC for MELOXICAM 15 MG TABLET has been published 534 times since Jul 13, 2016, and over the history we have for it it has declined 27.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0184 per EA |
|---|---|
| All-time high | $0.0253 (Jul 13, 2016) |
| All-time low | $0.0173 (Nov 20, 2024) |
| 52-week high | $0.0202 |
| 52-week low | $0.0184 |
| Median price | $0.0211 |
| Average price | $0.0211 |
| Largest weekly change | -17.1% (Nov 20, 2024) |
| Weeks tracked | 534 |
| Tracking since | Jul 13, 2016 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
American Health Packaging manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Meloxicam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MELOXICAM 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MELOXICAM 15 MG TABLET, manufactured by American Health Packaging, is $0.0184 per EA (NDC 60687019901), effective Sep 30, 2026.
How has the price of MELOXICAM 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for MELOXICAM 15 MG TABLET has declined 27.3%. It has been tracked across 534 weekly CMS publications since Jul 13, 2016.
What are the highest and lowest recorded NADAC prices for MELOXICAM 15 MG TABLET?
Since Jul 13, 2016, the NADAC for MELOXICAM 15 MG TABLET has ranged from a low of $0.0173 (Nov 20, 2024) to a high of $0.0253 (Jul 13, 2016), with a median of $0.0211 per EA.
Are there cheaper alternatives to MELOXICAM 15 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MELOXICAM 15 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MELOXICAM 15 MG TABLET?
MELOXICAM 15 MG TABLET (NDC 60687019901) is labeled by American Health Packaging, and CMS classifies it as a generic product.